Given the rapidly developing changes in AD research criteria (e.g., Jack et al., 2018), AD biomarkers such as APOE-4 status and amyloid/tau positivity status should also be explored in relation to procedural learning. This evidence concerns the gene MAPT and Alzheimer disease.